RENDREA Trademark

Trademark Overview


On Friday, November 18, 2011, a trademark application was filed for RENDREA with the United States Patent and Trademark Office. The USPTO has given the RENDREA trademark a serial number of 85476689. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 11, 2016. This trademark is owned by Eli Lilly and Company. The RENDREA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; Veterinary prepara...
rendrea

General Information


Serial Number85476689
Word MarkRENDREA
Filing DateFriday, November 18, 2011
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 11, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 9, 2013

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, sleep disorders, urological disorders; antipsychotic pharmaceutical preparations; antidepressants; Veterinary preparations, namely, vaccines, oral and injectable antimicrobial preparations for the treatment and control of infectious diseases in food producing animals and livestock, immunorestorative biopharmaceuticals, and other medicinal drugs for the prevention and treatment of viral, infectious, and metabolic diseases in animals; medicated animal feed and water additives in the nature of dietary supplements for production enhancement for livestock; veterinary preparations for controlling and destroying vermin, namely, ectoparasiticides, insecticides and parasiticides; Veterinary hormone preparations and hormone preparation implants for animals, namely, progesterone, estrogen and testosterone; Veterinary preparations for food safety, food animal processing and food animal processing aids, namely, bacteriophage, antimicrobials and vaccines to reduce levels of food borne pathogens carried in or on livestock, poultry or meat and to inhibit microbial decomposition in food and animal feed; veterinary preparations, namely, medical diagnostic agents, tests, and preparations and substances to identify pathogens and residues of biological interest for veterinary use; Veterinary preparations for companion animals, namely, to treat parasitic infections, diabetes, endocrine disorders, obesity, blood disorders, dental and oral diseases, pain, inflammation, gastrointestinal disorders, central nervous system disorders, neurological and neurodegenerative disorders, cardiovascular conditions, dermatologic conditions, urogenital and urinary conditions, osteoarthritis, otitis, wound healing, infections, allergy atopic conditions, liver diseases and disorders and nonsurgical sterilization, namely, hormones for the control/prevention of reproductive functions; veterinary preparations for treating and preventing fleas on companion animals; veterinary preparations, namely, vaccines for companion animals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 28, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, July 11, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, July 11, 2016ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, September 26, 2015EXTENSION 5 GRANTED
Thursday, September 17, 2015EXTENSION 5 FILED
Friday, September 25, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 17, 2015TEAS EXTENSION RECEIVED
Saturday, June 13, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 12, 2015EXTENSION 4 GRANTED
Thursday, May 21, 2015EXTENSION 4 FILED
Thursday, May 21, 2015TEAS EXTENSION RECEIVED
Thursday, December 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 3, 2014EXTENSION 3 GRANTED
Tuesday, November 25, 2014EXTENSION 3 FILED
Tuesday, November 25, 2014TEAS EXTENSION RECEIVED
Tuesday, June 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 9, 2014EXTENSION 2 GRANTED
Tuesday, June 3, 2014EXTENSION 2 FILED
Tuesday, June 3, 2014TEAS EXTENSION RECEIVED
Saturday, January 18, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 17, 2014EXTENSION 1 GRANTED
Thursday, November 21, 2013EXTENSION 1 FILED
Friday, January 17, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 13, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, November 21, 2013TEAS EXTENSION RECEIVED
Tuesday, June 4, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 9, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 9, 2013PUBLISHED FOR OPPOSITION
Wednesday, March 20, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 4, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 4, 2013ASSIGNED TO LIE
Wednesday, February 20, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 19, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 19, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 19, 2013TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, September 19, 2012NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 19, 2012FINAL REFUSAL E-MAILED
Wednesday, September 19, 2012FINAL REFUSAL WRITTEN
Friday, August 31, 2012TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 31, 2012CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 31, 2012TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 6, 2012NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 6, 2012NON-FINAL ACTION E-MAILED
Tuesday, March 6, 2012NON-FINAL ACTION WRITTEN
Tuesday, March 6, 2012ASSIGNED TO EXAMINER
Monday, November 28, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, November 22, 2011NEW APPLICATION ENTERED IN TRAM